Evidence mapPaperPMID 42583595Full record

ArticleAnnals of medicine and surgery (2012)2026

Prevalence of type 1 and type 2 diabetes among chronic kidney disease patients and laboratorial differences between diabetics and non-diabetics.

Ahmad Almouselli, Abdullah Shyah, Mohammad Basheer Alameer, Omar Al Emam, Inaam Almouselli, Dana Al Junaidi, Taghreed Hmoud

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmad AlmouselliFaculty of Medicine, Syrian Private University, Damascus, Syria.
Abdullah ShyahFaculty of Medicine, Syrian Private University, Damascus, Syria.
Mohammad Basheer AlameerFaculty of Medicine, Damascus University, Damascus, Syria.ORCID https://orcid.org/0009-0001-7156-567X
Omar Al EmamFaculty of Medicine, Syrian Private University, Damascus, Syria.
Inaam AlmouselliFaculty of Medicine, Damascus University, Damascus, Syria.
Dana Al JunaidiFaculty of Medicine, Syrian Private University, Damascus, Syria.
Taghreed HmoudFaculty of Medicine, Syrian Private University, Damascus, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic kidney disease (CKD) imposes a significant burden on patients and the entire healthcare system. Over the years, the incidence of CKD has been rising in the Arab world, primarily due to increased rates of diabetes and hypertension - the leading causes of CKD. Syrians face a higher risk of diabetes and hypertension, exacerbated by the ongoing crisis in the country. No previous papers discussing CKD among diabetic Syrian patients have been published. Methods: We conducted an examination of 297 patients' charts at the kidney surgical hospital in Damascus, Syria. Our objectives were to assess the prevalence of diabetes and hypertension among these patients, explore associated demographic factors, and investigate changes in serum creatinine, urea, fasting blood glucose levels, and the Modification of Diet in Renal Disease (MDRD) score among diabetic CKD patients compared to non-diabetic patients. Results: Among the studied patients, 64.6% were over 50, while 61.6% were males and 35.4% were diabetic. Patients with diabetes had lower creatinine levels upon admission than non-diabetics. The correlation between fasting blood glucose levels and each of serum creatinine, urea, and MDRD was not statistically significant. Conclusions: Despite the increasing incidence of diabetes, this study reveals that the prevalence of diabetes among CKD patients in Syria is similar to that observed globally. The ongoing crisis in Syria underscores the urgency of addressing CKD risk factors and implementing effective preventive measures.

Indexed as

chronic kidney diseasediabetesdiabetic nephropathyMDRD

Identifiers

PMID42583595
PMCPMC13461047

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.